On July 9-12, 2018, the INNOPROM International Industrial Exhibition was held in Yekaterinburg, where a stand of the Ural Biomedical Cluster was presented too. The exhibition's format provided for active communication between business and representatives of the Government of the Russian Federation, the Sverdlovsk region and foreign countries. It helped the exhibition participants to get familiar with innovative technologies, establish trade and economic bonds, promote products of Russian enterprises to new markets and implement promising investment projects.
At the Ural Biomedical Cluster's stand, seven participants of the non-profit partnership presented their products. First of all, it was the Medsintez plant, whose specialists had developed and launched the manufacturing of such unique products as finished dosage forms of Rosinsulin, genetically engineered human insulin, and Triazavirin, an innovative antiviral drug.
As Chairman of the Cluster Supervisory Board Alexander Petrov emphasized in his interview, “The implementation of the 'Import-Substituting Production of Genetically Engineered Human Insulin Based on Domestic Substance' project is approaching its final stage. The Medsintez Plant is ready to launch production of insulin based on its own producer bacteria: in September 2017, the company registered its proprietary substance, Rosinsulin, and in January this year, an application was submitted to register the Aspart insulin substance.”
Additionally, as part of strategic partnership with the international Bayer corporation, a new-generation antibiotic Avelox is now produced at the plant.
Ural Biomedical Company, a cluster member, presented its innovative product, AversGel, created using components of a certified stem cell line.
Korea, a state partner of Innoprom 2018, also presented natural herb-based cosmetics at its stand.
However, the technology of creating drugs based on human cells, which was developed and implemented by Ural Biomedical Company's experts, is the future of regenerative medicine.
The QualityMed medical centre successfully demonstrated to the exhibition visitors the possibilities of lab diagnostics.
Along with that, at the Ural Biomedical Cluster's stand, Medin-N products were presented: Sabfil, the innovative absorbable surgical suture, and an absorbable ophthalmic surgical nail stub, a unique proprietary development.
Representatives of the Ural State Medical University, the Tronitek company and Innovator, a small innovation business, actively communicated with the visitors.
Three quarters of the exhibition visitors were representatives of professional communities interested in modern technological solutions that can contribute to the technological growth of all sectors, including the pharmaceutical industry.
The business program was an important part of the exhibition. It focused on the possibility to implement and use innovative high-tech solutions in our everyday life.
An important event of the Forum was the presentation of Unified Industrial Map, a new educational project. Medsintez, which is going to be its member, has assumed an obligation to make schoolchildren familiar with some specifics of the pharmaceutical production.